A federal jury in Delaware put US biotech major Amgen (Nasdaq: AMGN) on the hook Thursday for at least $271.2 million in ...

Regeneron’s lead counsel was Jonathan D. Polkes of White & Case LLP.

The usual maintenance dosage of Otezla (apremilast) is two 30-mg doses per day. It’s important to take the Otezla dosage your doctor prescribes. Otezla belongs to a class of drugs called disease ...

and Otezla ® (apremilast) to convince pharmacy benefit managers (PBMs) to select Repatha ® (evolocumab) as the exclusive PCSK9 category product over Praluent ® (alirocumab). The jury found that ...

and Otezla (apremilast) to convince pharmacy benefit managers (PBMs) to select Repatha (evolocumab) as the exclusive PCSK9 category product over Praluent (alirocumab). The jury found that Amgen ...

The Psoriatic Arthritis Long-t erm Assessment of Clinical Efficacy (PALACE) trial programme found Otezla to be superior to placebo but "compared with TNF-alpha inhibitors, apremilast was the ...

Celgene's drug Otezla (apremilast) is an oral, selective inhibitor of phosphodiesterase 4 (PDE4) and gained its first approval in March this year for the treatment of psoriatic arthritis.

Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast), our acquisitions of ChemoCentryx, Inc. or Horizon Therapeutics plc (including the prospective performance and outlook of ...

Amgen today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial ...